Evidence map›Paper›PMID 32823952›Full record

ArticleCancers2020

YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms.

Thomas G Johnson, Karin Schelch, Kaitao Lai, Kamila A Marzec, Marina Kennerson, Michael Grusch, Glen Reid, Andrew Burgess

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Thomas G JohnsonThe Asbestos Diseases Research Institute (ADRI), Concord Hospital, Concord, Sydney 2139, Australia.
Karin SchelchInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Kaitao LaiThe ANZAC Research Institute, Concord Repatriation General Hospital, Sydney 2139, Australia.ORCID 0000-0002-9420-9352
Kamila A MarzecThe ANZAC Research Institute, Concord Repatriation General Hospital, Sydney 2139, Australia.
Marina KennersonThe ANZAC Research Institute, Concord Repatriation General Hospital, Sydney 2139, Australia.
Michael GruschInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5486-9340
Glen ReidDepartment of Pathology, The University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0001-6465-5223
Andrew BurgessThe ANZAC Research Institute, Concord Repatriation General Hospital, Sydney 2139, Australia.ORCID 0000-0003-4536-9226
The University of Sydney · AUMedical University of Vienna · ATConcord Repatriation General Hospital · AUMaurice Wilkins Centre · NZ

Funding

Austrian Science Fund T 1062 Firnberg ProgramNational Breast Cancer Foundation IIRS-18-103
6 · The paper itself

Abstract

Y-box binding protein-1 (YB-1) is a multifunctional oncoprotein that has been shown to regulate proliferation, invasion and metastasis in a variety of cancer types. We previously demonstrated that YB-1 is overexpressed in mesothelioma cells and its knockdown significantly reduces tumour cell proliferation, migration, and invasion. However, the mechanisms driving these effects are unclear. Here, we utilised an unbiased RNA-seq approach to characterise the changes to gene expression caused by loss of YB-1 knockdown in three mesothelioma cell lines (MSTO-211H, VMC23 and REN cells). Bioinformatic analysis showed that YB-1 knockdown regulated 150 common genes that were enriched for regulators of mitosis, integrins and extracellular matrix organisation. However, each cell line also displayed unique gene expression signatures, that were differentially enriched for cell death or cell cycle control. Interestingly, deregulation of STAT3 and p53-pathways were a key differential between each cell line. Using flow cytometry, apoptosis assays and single-cell time-lapse imaging, we confirmed that MSTO-211H, VMC23 and REN cells underwent either increased cell death, G1 arrest or aberrant mitotic division, respectively. In conclusion, this data indicates that YB-1 knockdown affects a core set of genes in mesothelioma cells. Loss of YB-1 causes a cascade of events that leads to reduced mesothelioma proliferation, dependent on the underlying functionality of the STAT3/p53-pathways and the genetic landscape of the cell.

Indexed as

apoptosiscell cycleG2/M checkpointMDM2mitosisp21p53RNA-seqSTAT3Y-box protein-1

Identifiers

PMID32823952
PMCPMC7464182
OpenAlexW3049287709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.